D. E. Shaw & Co., Inc. - ODONATE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ODONATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$505,000
-25.6%
374,195
+60.4%
0.00%
-100.0%
Q3 2021$679,000
-42.8%
233,340
-31.4%
0.00%0.0%
Q2 2021$1,187,000
+15.4%
340,068
+13.0%
0.00%0.0%
Q1 2021$1,029,000
-64.5%
300,832
+99.1%
0.00%
-66.7%
Q4 2020$2,901,000
+110.8%
151,100
+47.5%
0.00%
+200.0%
Q3 2020$1,376,000
-67.9%
102,453
+1.4%
0.00%
-80.0%
Q2 2020$4,280,000
+53.9%
101,075
+0.4%
0.01%
+25.0%
Q1 2020$2,781,000
-23.5%
100,707
-10.1%
0.00%0.0%
Q4 2019$3,634,000
+99.2%
111,997
+59.8%
0.00%
+100.0%
Q3 2019$1,824,000
+412.4%
70,084
+281.7%
0.00%
Q3 2018$356,000
-22.4%
18,359
-11.7%
0.00%
-100.0%
Q2 2018$459,000
-40.2%
20,782
-42.6%
0.00%0.0%
Q1 2018$767,00036,1910.00%
Other shareholders
ODONATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 15,514,566$297,880,00045.48%
Boxer Capital, LLC 5,607,086$107,656,0003.46%
Samsara BioCapital, LLC 815,421$15,656,0001.57%
GSA CAPITAL PARTNERS LLP 148,148$2,844,0000.46%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,211,728$23,265,0000.38%
RTW INVESTMENTS, LP 1,000,139$19,203,0000.32%
Sio Capital Management, LLC 75,500$1,450,0000.30%
AlphaCentric Advisors LLC 29,594$568,0000.24%
Birchview Capital, LP 20,000$384,0000.22%
Aristides Capital LLC 33,226$638,0000.22%
View complete list of ODONATE THERAPEUTICS INC shareholders